Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Journal of Crohn'S & Colitis|September 11, 2013
Disease severity in familial cases of IBDM Andreu, L Márquez, E Domènech, et al.Inflammatory Bowel Diseases|May 28, 2011
Long-term durability of response to adalimumab in Crohn's diseaseM Chaparro, J Panés, V García, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2021
Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registryA Hernández-Camba, L Arranz, I Vera, et al.Alimentary Pharmacology & Therapeutics|June 22, 2019
Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registryM Iborra, B Beltrán, A Fernández-Clotet, et al.Alimentary Pharmacology & Therapeutics|August 29, 2013
Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic eraT Nunes, M J Etchevers, E Domènech, et al.The American Journal of Gastroenterology|May 2, 2018
Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA RegistryI Ordás, E Domènech, M Mañosa, et al.The American Journal of Gastroenterology|May 24, 2017
Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida RegistryMaría Chaparro, M Ramas, J M Benítez, et al.The American Journal of Gastroenterology|January 16, 2013
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel diseaseM J Casanova, M Chaparro, E Domènech, et al.The American Journal of Gastroenterology|July 5, 2017
Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter StudyI Ordás, E Domènech, M Mañosa, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2023
Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel diseaseA Martin-Cardona, D Horta, P Florez-Diez, et al.Pageof 5